Close Menu

The US Food and Drug Administration has cleared sequencing-based cystic fibrosis assays, the Wall Street Journal reports.

The tests, from Illumina, include the company's MiSeqDx Cystic Fibrosis 139-Variant Assay, which examines specific spots of the CFTR gene, and its Illumina MiSeqDx Cystic Fibrosis Clinical Sequencing Assay, which sequences the CFTR gene and compares it to a reference, according to an FDA press release

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

In Science this week: chromatin accessibility of microglia during fetal development, and more.